Physician

Amir R Haghighat, MD

According to 2025 Medicare claims, Amir Haghighat, MD (NPI: 1235197518) practices interventional cardiology in the Panama City-Panama City Beach, FL market, with the plurality of this provider's patient population coming from Bay, FL. This provider's primary affiliated billing organization is ECONFINA CARDIOLOGY GROUP, PA (NPI: 1609801257; TIN: 59-2005970) and primary practice location at 32405-3359.

Haghighat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,232 traditional Medicare patients, billed 6,573 HCPCS/CPT codes, and received $705,275 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,182 prescription claims across 1,046 beneficiaries totaling $1,270,042 in drug costs, led by Eliquis (Apixaban). DME data shows 19 claims. Open Payments data shows 74 records totaling $3,489. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $664,053 and ending at $705,275. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $145,340 to $1,270,042. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $17,783 and ending at $48,302.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,345	8,342	$664,053
2016	3,450	9,048	$695,295
2017	3,097	7,314	$565,025
2018	2,680	6,906	$506,226
2019	1,938	4,820	$390,780
2020	2,497	6,510	$543,477
2021	2,245	6,209	$660,061
2022	2,387	6,877	$767,919
2023	2,070	5,986	$588,621
2024	2,232	6,573	$705,275

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	412	2,017	$145,340
2016	485	2,478	$210,103
2017	510	2,662	$256,404
2018	554	3,036	$333,939
2019	546	2,870	$294,199
2020	682	3,445	$454,295
2021	790	4,456	$709,397
2022	802	4,511	$839,647
2023	843	4,944	$1,078,834
2024	1,046	6,182	$1,270,042

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	18	$207
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	11	27	$53,886
2019	N/R	50	$55,821
2020	N/R	24	$1,043
2021	N/R	15	$32,246
2022	N/R	18	$41,546
2023	N/R	48	$29,632
2024	N/R	19	$48,302

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,320	1,608	$98
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	212	213	$75
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	256	508	$63
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	163	163	$53
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,039	1,061	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	410	23,458	$438,953
Entresto	Sacubitril/Valsartan	191	12,323	$268,376
Xarelto	Rivaroxaban	104	7,810	$134,376
Farxiga	Dapagliflozin Propanediol	112	7,680	$132,961
Repatha Sureclick	Evolocumab	103	4,366	$81,952

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	19	$48,302

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	74	$3,489	Endologix LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amir R. Haghighat, MD?

Tedicare shows public-source Medicare data for Amir R. Haghighat, MD (NPI 1235197518), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amir R. Haghighat, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amir R. Haghighat, MD?

Amir R. Haghighat, MD is linked to ECONFINA CARDIOLOGY GROUP, PA (billing NPI 1609801257) in the available physician profile data.

Does Amir R. Haghighat, MD have Open Payments data?

Amir R. Haghighat, MD has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.